FOI release

CEC 203042 - generic tazocin allergy reports

Case reference FOI2024/00658

Received 21 October 2024

Published 22 November 2024

Request

We have been made aware of 2 severe allergic reactions to generic tazocin in our emergency department over the weekend. We believe at least one of them to be a true anaphylaxis reaction and has since passed away. Both patients were not listed as allergic to pencillins, having received penicillins in the past and the 2nd patient had previously received courses of tazocin in the past (as recently as September 2024) without issue. Our medical colleagues will be producing yellow card reports in due course, but I wanted to contact you to see if there have been any increased reports relating to tazocin? And also any in particular to the generic brand Antibiotice?

Response

see attached

Documents

• FOI2024.00658 redacted for publication.pdf (102.1 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.